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Neural stem cells are widely studied for their therapeutic potential and for the insight they reveal into the mechanisms of
brain development. The latest advances in neural stem cell research are the topic of this issue’s Neurobiology Select.
These findings include a simple protocol for reprogramming human neural stem cells to pluripotency and a report demon-
strating that transplanted neural stem cells can have a therapeutic benefit by promoting the survival of endogenous
neurons. Other work explores the mechanisms regulating neurogenesis in vivo, including the impact of transcriptional
regulation, cell-cycle duration, and chromatin remodeling.
A One-Ingredient Recipe for Pluripotency
Making human induced pluripotent stem (iPS) cells just got substantially
easier. Kim et al. (2009) now show that human neural stem cells (NSCs)
can be coaxed into pluripotency following the introduction of a single factor,
the transcription factor OCT4. In prior work these authors demonstrated
that mouse adult neural stem cells could be reprogrammed to pluripotency
by the introduction of murine Oct4 alone. Their latest efforts bridge the
species gap, providing a simpler means with which to create lines of
human iPS cells for possible therapeutic uses. They show that the
ingredients of the now famous four factor cocktail (OCT4, SOX2, c-Myc,
and KLF4) are well-represented in neural stem cells, with all but OCT4 being
expressed endogenously. Adding OCT4 to this pre-made mix completes
the potent brew. This technical achievement should further intensify the
search for compounds that imitate the effects of pluripotency factors,
most notably OCT4. In addition, these finding add to a growing body of
evidence that endogenously expressed pluripotency factors have the
capacity to contribute to the generation of iPS cells. A potential corollary
is that expression profiling should offer guidance as to which pluripotency
factors might be needed to transform other tissue-specific stem cells into iPS cells.
J.B. Kim et al. (2009). Nature. Published online August 28, 2009. 10.1038/nature08436.
Human NSCs Make a Lasting Impact
To have a therapeutic benefit, transplanted neural stem cells may not need
to replace lost or damaged neurons. According to surprising new work by
Tamaki et al. (2009), transplanted neural stem cells could instead foster
an environment that is more supportive to the survival of endogenous
neurons teetering on the brink of death. The authors report that human
neural stem cells (grown as neurospheres) are neuroprotective when trans-
planted into the brains of embryonic mice lacking the enzyme palmitoyl
protein thoiesterase-1(Ppt1). In humans the loss of PPT1 leads to the fatal
neurodegenerative disease infantile neuronal ceroid lipofuscinosis (INCL),
and Ppt knockout mice recapitulate many features of the human disease,
including elevated accumulation of lipofuscin and a progressive loss of
motor coordination. Following the stem cell transplantation, the engrafted cells replace themissing Ppt1, and themice exhibit
a decrease in the amount of lipofuscin and an enhancement in the survival of endogenous neurons. The net effect of this treat-
ment is to slow the decline in motor function. The authors also provide evidence that the mechanism for this benefit may
involve the uptake into host neurons of PPT1 that has been secreted by the engrafted human cells. Future effortsmay examine
whether the transplanted stem cells also improve the survival of endogenous neurons through other neuroprotective mech-
anisms. Regardless of the mechanistic details, these findings provide clear inspiration for ongoing efforts to treat a broad
spectrum of nervous system disorders with stem cell transplants.
S.J. Tamaki et al. (2009). Cell Stem Cell 5, 310–319.
Sox2 and Sonic Hedgehog Team up to Fight Stem Cell Loss
The maintenance of neural stem cells requires both intrinsic and extrinsic factors. Recent findings by Favaro et al. (2009)
describe a previously unrecognized autocrine signaling mechanism for neural stem cell maintenance—the regulation of sonic
hedgehog expression by the pluripotency factor Sox2. Previous work has linkedmutations in the human Sox2 gene to defects
in the hippocampus, a region of the brain involved in memory formation. The new report shows that Sox2 deletion in the
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embryonic mouse brain results in abnormal development of the hippocampus after birth due to a reduction in the number of
neural stem cells. Interestingly, this phenotype mirrors what is observed when signaling by either sonic hedgehog or Wnt3a is
disrupted during this same stage of hippocampal development. The authors then observe thatSox2 deletion leads to a subse-
quent loss ofWnt3a and sonic hedgehog expression and show that the effects of Sox2 deficiency on the hippocampus can be
partially rescued by administration of a sonic hedgehog agonist. At least for sonic hedgehog the regulation by Sox2 appears to
be direct, with chromatin immunoprecipitation experiments demonstrating that Sox2 binds chromosomal regions in proximity
to the sonic hedgehog gene. Future workmay determine whether similar autocrine pathways are critical to themaintenance of
other stem cell populations, including embryonic stem cells.
R. Favaro et al. (2009). Nat. Neurosci. Published online September 6, 2009. 10.1038/nn.2397.
Speeding through G1 Delays Neurogenesis
According to a recent report by Lange et al. (2009), the duration of the cell cycle has
a marked impact on the capacity of neural stem cells to generate neural progeny.
Previous work has shown that cell-cycle lengthening in neural stem cells can cause
their switch from expansion to neurogenesis, but it has been unclear whether short-
ening the cell cycle would be sufficient to trigger progenitor expansion. The new find-
ings make clear that cell-cycle regulation is no bystander in this process. Working in
mice, the authors show that heightened expression of cyclin-dependent kinase
4 (cdk4) and cyclinD1 (introduced via an electroporated plasmid) shortens G1 in
neural stem cells. This leads to a delay in neurogenesis, which is coupled to an
expansion of basal (or intermediate) progenitors in the subventricular zone.
Conversely, neurogenesis is enhanced when G1 is lengthened by reducing cdk4/
cyclinD1 expression using RNA interference. Although the mechanisms by which
cell-cycle lengthening impacts the switch from proliferation to differentiation are
currently unclear, these findings will likely motivate similar efforts to assess the influ-
ence of G1 lengthening on the differentiation of numerous other cell types.
C. Lange et al. (2009). Cell Stem Cell 5, 320–331.
Polycomb Sets Limits on Neurogenic Potential
In the developing neocortex of themammalian brain, neurons aremade prior to astrocytes despite the fact that both cell types
arise from a common progenitor, the neural stem cell. Findings by Hirabayashi et al. (2009) now provide insight into what regu-
lates the timing of this dramatic switch in the fate of neural stem cell progeny. The authors show that neural progenitor cells
lose their capacity to respond to signals through the canonical Wnt pathway at a late stage of neocortical development. At
earlier stages of brain development, Wnt signals have been shown to trigger an upregulation of the neurogenic transcription
factors Neurogenin 1 (Ngn1) and Ngn2. The authors report that the progressive loss in the ability to induce Ngn1 expression
coincideswith a change in chromatin structure at the ngn1 and ngn2 genes, which exhibit a transition from an open to a closed
state. This closed state is characterized by an increase in histone H3 lysine 27 trimethylation, a modification that has often
been linked in developmental contexts to regulation by the polycomb group complex (PcG). To explore this possible connec-
tion between PcG and the timing of neurogenesis, the authors examine neural progenitor cells in mice deficient in essential
PcG components: the ubiquitin ligase Ring1B or the histone methyltransferase Ezh2. They show that in either mutant mouse,
the period of neurogenesis is prolonged to favor the differentiation of neurons over astrocytes and that disruption of PcG alle-
viates repression of Ngn1 expression. These findings set the stage for future work that may provide an in-depth analysis of the
gene expression program regulated by PcG at the transition between neurogenesis and astrogenesis.
Y. Hirabayashi et al. (2009). Neuron 63, 600–613.
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